2025 Autumn Intake – Popular Programs Still Open!

Don't miss your chance! We are still accepting applications for our high-demand programs starting in Fall 2025. You can still apply for the Bachelor's in International Chinese Language Education, the Clinical Medicine (1+5) program, and the non-degree Chinese Language course. With limited seats available and high applicant interest, we encourage you to submit your application without delay to secure your place.

Program Details

Basic information

Intake: 2025 Autumn

City: Kunming

Degree: Non-degree

Teaching Language: Chinese

Age: 18 to 45

Application deadline: Nov 15,2025

Program name & ID

Chinese Language (One Semester) SNC2510280042

Chinese Language (1 year) SNC2510280044

Fee structure

One semester

Tuition fee: 3500RMB/semester

Accommodation fee-Quad room: 1500RMB/semester

One year

Tuition fee: 5500RMB/year

Accommodation fee-Quad room: 3000RMB/year

Basic information

Intake: 2025 Autumn

City: Shenyang

Degree: Bachelor

Teaching Language: Chinese

Age: 16 to 30

Application deadline: Nov 30,2025

Program name & ID

Clinical Medicine（1+5） SBC25070828976

Fee structure

Tuition fee: 20000RMB/year

Accommodation fee-Double room: 5000RMB/year

Basic information

Intake: 2025 Autumn

City: Ganzhou

Degree: Bachelor

Teaching Language: Chinese

Age: 17 to 25

Application deadline: Nov 04,2025

Program name & ID

International Chinese Language Education CBC2507020002

Fee structure

Original tuition fee: 12000RMB/year

Accommodation fee-Double room: 3000RMB/year

1. School Award Class A - Tuition fee after scholarship: 0RMB/year

2. School Award B - Tuition fee after scholarship: 6000RMB/year

3. School Award "the Belt and Road": - Tuition after scholarship: 6000RMB/year

First year of education: Admission is generally free of charge .

Current students: Can apply for exemption and half scholarship.

How to Apply

Step 1: Sign up on www.eduprchina.com.

Step 2: Fill in your personal info and upload basic documents to get your EDUPRCHINA agent account approval.